Marburg virus pathogenesis - differences and similarities in humans and animal models

Kyle Shifflett1, Andrea Marzi2

  • 1Laboratory of Virology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, Rocky Mountain Laboratories, National Institutes of Health, 903 South 4th Street, Hamilton, MT, 59840, USA.

Virology Journal
|January 1, 2020
PubMed

Insights

Marburg virus (MARV) disease is deadly, with no approved treatments. This review evaluates animal models for their accuracy in mimicking human Marburg virus pathogenesis to aid in countermeasure development.

Area of Science:

  • Virology
  • Pathogenesis
  • Comparative Medicine

Background:

  • Marburg virus (MARV) causes severe disease with high mortality rates (up to 90%).
  • MARV outbreaks are sporadic, posing challenges for diagnosis, treatment, and countermeasure testing due to resource limitations and ethical/logistical hurdles.
  • Currently, no vaccines or treatments for Marburg virus disease are approved.

Purpose of the Study:

  • To compare various animal models against human Marburg virus disease pathogenesis.
  • To evaluate the effectiveness of animal models in recapitulating key aspects of MARV infection in humans.

Main Methods:

  • Literature review comparing published human Marburg virus disease pathogenesis with data from various animal models.
  • Analysis of the accuracy of animal models in representing MARV-induced pathology and clinical outcomes.

Main Results:

  • Identification of specific animal models that best reflect human Marburg virus disease.
  • Highlighting limitations of current animal models in fully recapitulating human pathogenesis.

Conclusions:

  • Accurate animal models are crucial for assessing the efficacy of potential Marburg virus vaccines and treatments.
  • Further refinement of animal models is needed to improve the prediction of countermeasure effectiveness in humans.